Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2286 (LINC02286)

Target: LINC02286
Molecular classification: Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other

Overview

Long intergenic non-protein coding RNA 2286 (LINC02286) is a human long intergenic non-coding RNA (lincRNA) gene. lincRNAs are transcribed RNA molecules longer than 200 nucleotides that do not overlap protein-coding regions and have little or no protein-coding potential. Typical features and functions for this RNA class (but not established for LINC02286 specifically) include regulation of gene expression in *cis* or *trans*, chromatin remodeling, influencing genome architecture, and acting as scaffolds for ribonucleoprotein complexes. The functions of most human lincRNAs, including LINC02286, remain experimentally uncharacterized

Other names: LINC02286

Mechanism of action

None described for this specific lincRNA; lincRNAs in general can act via chromatin modification, modulation of transcription factor binding, acting as competing endogenous RNAs (ceRNAs), or scaffolding RNA/protein complexes

Biological functions

While the specific function of LINC02286 is not yet uniquely reported in literature or major genetic databases, as a member of the lincRNA class, inferred functions include:Chromatin remodelingTranscriptional regulationFine-tuning expression of neighboring genesPotential scaffolding of protein complexesModulation of genome architecture

Disease associations

No direct disease associations or functional studies are reported for LINC02286 in current literature or curated databases. Inferred from the lincRNA class:Other (potential, but unconfirmed, involvement in cancer, cell differentiation, or disease-related gene regulation)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2286 (LINC02286).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2286 (LINC02286).

Explore the full profile